Harborside Press

BroadcastMed Announces New Chief Executive Officer and Expanded Leadership Team

Retrieved on: 
Wednesday, July 26, 2023
NextGen Healthcare, Fintech, Medicine, Senior, Marketing, Culture, WebMD, DuPont, Ford, GE, Digitel GSM, Harborside Press, Schweizer, Aegis, Endeavor Business Media, Organization, Cardinal Health, Enzai: Falsely Accused, Gus Malzahn, Hospital, Acquisition, Publishing, Physician, Engineering, Chief digital officer, Capital, Pleasure, Cox Enterprises, Growth, Verizon Communications, Digital, Harborside, AutoWeb, Management, Experian

FARMINGTON, Conn., July 26, 2023 /PRNewswire/ -- BroadcastMed, the leading healthcare marketplace that provides trusted clinical content, powerful engagement and industry insights to healthcare professionals, medical institutions and manufacturers, service providers, and pharmaceutical companies, announces today its expanded leadership team, including appointing Charlie Lee as Chief Executive Officer and a member of the company's Board of Directors.  These strategic additions aim to accelerate BroadcastMed's growth trajectory and strengthen its leadership position in the market.

Key Points: 
  • Charlie has assembled a world-class leadership team that is creating significant internal and external market momentum.
  • Lee joined BroadcastMed in January 2023 as Chief Operating Officer and brings over twenty years of executive experience in high-growth, publicly traded and PE-backed digital, technology, and marketplace companies.
  • To support Lee, several individuals have joined BroadcastMed's executive team, many from previous acquisitions:
    Karen Auiler has been promoted to the position of BroadcastMed's Chief Operating Officer.
  • He brings 25 years of financial leadership experience, including Chief Financial Officer or other executive finance roles in public and PE-backed organizations including GE, Cox Automotive, NextGen Healthcare, AutoWeb and MeridianLink.

Patrick Delaney Named New Executive Director of NCCN Foundation

Retrieved on: 
Monday, February 8, 2021
National Comprehensive Cancer Network, NCCN, Harborside Press

PLYMOUTH MEETING, Pa., Feb. 8, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network ( NCCN ) today announced the appointment of Patrick Delaney as incoming Executive Director for the NCCN Foundation .

Key Points: 
  • PLYMOUTH MEETING, Pa., Feb. 8, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network ( NCCN ) today announced the appointment of Patrick Delaney as incoming Executive Director for the NCCN Foundation .
  • "I am thrilledto join the teamat NCCN as ExecutiveDirector of the NCCN Foundation," said Delaney.
  • The NCCN Guidelines for Patients provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation .
  • The NCCN Foundation was founded by the National Comprehensive Cancer Network (NCCN) to empower people with cancer and advance oncology innovation.

Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy

Retrieved on: 
Monday, December 21, 2020
National Comprehensive Cancer Network, NCCN, Multiple myeloma, Oncology, Health care, Medicine, Medical specialties, Journal of the National Comprehensive Cancer Network, Harborside Press

In December 2020, National Comprehensive Cancer Network (NCCN) added three different XPOVIO combination regimens to its Clinical Practice Guidelines in Oncology (NCCN Guidelines) for previously treated multiple myeloma.

Key Points: 
  • In December 2020, National Comprehensive Cancer Network (NCCN) added three different XPOVIO combination regimens to its Clinical Practice Guidelines in Oncology (NCCN Guidelines) for previously treated multiple myeloma.
  • A Phase 3 randomized, controlled, open-label and multicenter BENCH trial has also received the IND approval from the National Medical Products Administration (NMPA)in China.
  • XPOVIOoffers patients with rrMM and their physicians the first oral SINE compound and makes more treatment options available to cancer patients with critical unmet medical needs."Dr.
  • *XPOVIOis a registered trademark of Karyopharm Therapeutics Inc.;
    NCCNis a registered trademark of National Comprehensive Cancer Network.

Cleveland Clinic's Beth Faiman Appointed Editor-in-Chief of the Journal of the Advanced Practitioner in Oncology

Retrieved on: 
Friday, August 21, 2020
Oncology, Health in Morocco, Oncology nursing, Blood, APRN, Harborside Press

HUNTINGTON, N.Y., Aug. 21, 2020 /PRNewswire-PRWeb/ --On August 1, Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN, took the helm as the Editor-in-Chief of the Journal of the Advanced Practitioner in Oncology (JADPRO) .

Key Points: 
  • HUNTINGTON, N.Y., Aug. 21, 2020 /PRNewswire-PRWeb/ --On August 1, Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN, took the helm as the Editor-in-Chief of the Journal of the Advanced Practitioner in Oncology (JADPRO) .
  • She is currently an adult nurse practitioner in the Department of Hematologic Oncology and Blood Disorders at the Cleveland Clinic in Cleveland, Ohio.
  • The mission of the Journal of the Advanced Practitioner in Oncology (JADPRO) is to improve the quality of care for patients with cancer, support critical issues in advanced practice in oncology, and recognize the expanding contributions of advanced practitioners in oncology.
  • JADPRO is published by Harborside and is the official journal of the Advanced Practitioner Society for Hematology and Oncology (APSHO).

New PatientPoint Campaign Brings National Comprehensive Cancer Network Resources to Oncology Practices Nationwide

Retrieved on: 
Thursday, June 20, 2019
National Comprehensive Cancer Network, NCCN, Health, Harborside Press

PatientPoint is also promoting NCCN programs and evidence-based NCCN resources to patients, caregivers and oncology specialists.

Key Points: 
  • PatientPoint is also promoting NCCN programs and evidence-based NCCN resources to patients, caregivers and oncology specialists.
  • As part of the new campaign, PatientPoint will deliver information about NCCN resources in oncology waiting rooms, exam rooms and physician back office areas via its PatientPoint Communicate , PatientPoint Interact and PatientPoint Access engagement programs.
  • The National Comprehensive Cancer Network ( NCCN ) is a not-for-profit alliance of 28 leading cancer centers devoted to patient care, research, and education.
  • The NCCN Foundation was founded by the National Comprehensive Cancer Network (NCCN) to empower people with cancer and advance oncology innovation.